On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
Decoding the neurobiological underpinnings of psychiatric disorders such as addiction is critically linked to expanding insights obtained from the human brain which can inform targeted treatments. The important need for the development of novel non-addictive medications is particularly critical today to address the persistent opioid and overdose epidemic crisis facing society worldwide. The presentation will provide molecular insights gained from post-mortem studies of human heroin users and complementary mechanistic animal studies that identify specific epigenetic, neurodegenerative and synaptic plasticity biological processes that offer druggable targets for opioid use disorder.
SPEAKER BIOGRAPHY
Dr. Yasmin Hurd is Professor of Psychiatry, Neuroscience and Pharmacological Sciences as well as the Director for the Addiction Institute at the Icahn School of Medicine at Mount Sinai in New York. She is an internationally renowned neuroscientist whose translational research examines the neurobiology of substance use disorders and related psychiatric disorders with primary focus on opioid abuse and the developmental effects of cannabis. She is a member of both the National Academy of Sciences and the National Academy of Medicine.
